Aviva PLC Has $88.49 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Aviva PLC raised its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 973,421 shares of the company's stock after buying an additional 114,855 shares during the quarter. Aviva PLC owned about 0.12% of Colgate-Palmolive worth $88,494,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Colgate-Palmolive by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 81,303,059 shares of the company's stock valued at $7,391,261,000 after acquiring an additional 588,230 shares during the period. Geode Capital Management LLC raised its stake in shares of Colgate-Palmolive by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company's stock valued at $1,868,723,000 after purchasing an additional 324,683 shares in the last quarter. Norges Bank bought a new position in Colgate-Palmolive in the fourth quarter worth $912,375,000. Amundi boosted its stake in Colgate-Palmolive by 12.8% during the fourth quarter. Amundi now owns 9,200,144 shares of the company's stock worth $806,015,000 after buying an additional 1,040,604 shares in the last quarter. Finally, Barclays PLC raised its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after buying an additional 2,132,747 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Up 1.1 %

Shares of NYSE CL traded up $1.03 during midday trading on Thursday, reaching $91.26. The company's stock had a trading volume of 2,748,449 shares, compared to its average volume of 4,567,102. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a 50 day simple moving average of $90.24 and a 200-day simple moving average of $92.80. The stock has a market capitalization of $74.02 billion, a price-to-earnings ratio of 25.96, a PEG ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Remove Ads

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the firm posted $0.87 EPS. Equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive declared that its Board of Directors has authorized a share buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's management believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be given a dividend of $0.52 per share. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.28%. Colgate-Palmolive's payout ratio is 59.09%.

Analyst Ratings Changes

Several analysts recently commented on CL shares. TD Cowen decreased their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a research note on Wednesday, January 8th. Barclays lifted their price objective on Colgate-Palmolive from $83.00 to $89.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 27th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research report on Monday, March 31st. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the stock an "overweight" rating in a research note on Friday, March 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $102.06.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.